Search for Abstracts Find by Title, Author or Description Year Abstracts - 2025 - 2024 - 2023 - 2022 - 2021 - 2020 - 2019 - 2018 - 2017 - 2016 - 2015 - 2014 - 2013 - 2012 - 2011 - 2010 - 2009 Tags AB Applied Basic Science Basic Science BT Clinical Clinical-Chemotherapy-SSA-Biologics Clinical-NuclearMedicine-InterventionalRadiology-Imaging Clinical-PRRT-Nuclear Clinical-Surgical-Applied_Pathology O OT Other P Population Science Poster T Trials In Progress Search Reset Order by Title Alphabetical Title Reverse Alphabetical Most Recent First Oldest First Most popular first Last modified first [C47] Fasih - Surgical Cytoreduction vs Systemic therapy in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETS): NCDB Analysis. Published in 2023 Listed under Clinical Download [C46] Dumitra - Clinical utility of preoperative DOTATATE-PET in small bowel neuroendocrine tumors Published in 2024 Listed under Clinical Download [C46] Borbon - Peptide Receptor Radionuclide Therapy Improves Survival in Patients Who Progress After Resection of Gastroenteropancreatic Neuroendocrine Tumors Published in 2023 Listed under Clinical Download [C45] Poster - Nkie - Interaction Between Race and Insurance Coverage for Gastroenteropancreatic Neuroendocrine Tumor Outcomes Published in 2024 Listed under Clinical, Poster Download [C45] Nkie - Interaction Between Race and Insurance Coverage for Gastroenteropancreatic Neuroendocrine Tumor Outcomes Published in 2024 Listed under Clinical Download [C45] Lau - Grade progression in gastrointestinal neuroendocrine tumors Published in 2023 Listed under Clinical Download [C44] Shi - Incidence and prognostic analysis of neuroendocrine differentiation in CRC, GC, ESCC and BTC cohorts Published in 2024 Listed under Clinical Download [C44] Bell - Real-Time Prospective DAXX/ATRX Testing of 186 Consecutive Surgically Resected Pancreatic Neuroendocrine Tumors Reveals Loss of Expression Correlates with Distant Metastasis Published in 2023 Listed under Clinical Download [C43] Zhang - Accuracy of DOTATATE PET Imaging in the Preoperative Planning of Small Bowel Neuroendocrine Tumor Resection Published in 2023 Listed under Clinical Download [C43] Wornow - To Treat or Not to Treat: Resection of Primary Pancreatic Neuroendocrine Tumors in the Metastatic Setting Published in 2024 Listed under Clinical Download [C43] Poster - Wornow - To Treat or Not to Treat: Resection of Primary Pancreatic Neuroendocrine Tumors in the Metastatic Setting Published in 2024 Listed under Clinical, Poster Download [C43] Lui - Post-Operative Biochemical Surveillance Thresholds Can be Used to Monitor for Sympathetic Pheochromocytoma/Paraganglioma Recurrence and Metastasis Published in 2022 Listed under Clinical Download [C42] Poster - Evans - Loss of MGMT Protein Expression by Immunohistochemistry is Associated with Response to Capecitabine/Temozolomide in Neuroendocrine Neoplasms (NENs) Published in 2024 Listed under Clinical, Poster Download [C42] Pai - Small Intestinal NET Recurrence – When Why and How? Published in 2022 Listed under Clinical Download [C42] Luca - Treatment with Lutetium in a real-world setting: How does it affect patient experience and their time-toxicity? Published in 2023 Listed under Clinical Download [C42] Evans - Loss of MGMT protein expression by immunohistochemistry is associated with response to capecitabine/temozolomide in neuroendocrine neoplasms (NENs) Published in 2024 Listed under Clinical Download [C41] Yogo - Long-term Survival Outcomes After Minimally Invasive Surgery for Ileal Neuroendocrine Tumors Published in 2024 Listed under Clinical Download [C41] Pritzl - Spectrum of therapy-related clonal cytopenias and neoplasms after exposure to Lutetium-177-Dotatate Published in 2023 Listed under Clinical Download [C41] Poster - Yogo - Long-term Survival Outcomes After Minimally Invasive Surgery for Ileal Neuroendocrine Tumors Published in 2024 Listed under Clinical, Poster Download [C41] Chauhan - SSTR-2 Expression in Solid Tumors: An Immunohistochemistry Analysis Published in 2022 Listed under Clinical Download [C40] Winters - Implementation of dosimetry in clinical Lu177-DOTATATE therapy Published in 2024 Listed under Clinical Download [C40] Joseph - TP53 Mutation Portends a Worse Overall Survival in Patients with Advanced Grade 3 Well-Differentiated Neuroendocrine Tumors Published in 2022 Listed under Clinical Download [C40] Grewal - Evaluation of long-term hepatic adverse events in patients receiving Peptide Receptor Radionuclide Therapy (PRRT) following BLAND embolization Published in 2023 Listed under Clinical Download [C3] Vasconcelos - Real-World Evidence of Lenvatinib Use for Treatment of Metastatic Neuroendocrine Neoplasms Published in 2023 Listed under Clinical Download [C3] Uberroth - Prolonged Response to Dabrafenib/Trametinib in Metastatic Well-Differentiated Grade 3 Pancreatic Neuroendocrine Tumor (NET G3) with BRAF V600E Mutation Published in 2024 Listed under Clinical Download [C39] Winters - Dosimetry-guided 131I-mIBG Therapy in a Hemodialysis- Dependent Paraganglioma Patient Published in 2024 Listed under Clinical Download [C39] McElroy - Have We Accounted for Asians? A Critical Analysis of Racial Cancer Disparity Amongst Asian Pancreatic Neuroendocrine Tumor Patients Published in 2022 Listed under Clinical Download [C39] Grewal - Repeat Peptide Receptor Radionuclide Therapy in Neuroendocrine Neoplasms: A NET Center of Excellence Experience Published in 2023 Listed under Clinical Download [C38] Schnell - Radioactivity in drained body cavity fluid following peptide receptor radionuclide therapy with 177Lu DOTATATE in patients with advanced neuroendocrine tumors Published in 2024 Listed under Clinical Download [C38] Poster - Schnell - Radioactivity in drained body cavity fluid following peptide receptor radionuclide therapy with 177Lu DOTATATE in patients with advanced neuroendocrine tumors Published in 2024 Listed under Clinical, Poster Download [C38] Gupta - Are there any clinical factors associated with PRRTrefractoriness in NET patients? Published in 2023 Listed under Clinical Download [C38] Concors - Increased Incidence, Prevalence, and Surgical Management of Enteropancreatic Neuroendocrine Tumors Is Associated with Improvements in Survival - A Contemporary Analysis Published in 2022 Listed under Clinical Download [C37] Wahl - Preliminary safety and efficacy data of [212Pb]VMT- α -NET in somatostatin receptor 2 (SSTR2) expressing neuroendocrine tumors (NETs) Published in 2024 Listed under Clinical Download [C37] Remick - Initial Experience Using 0.55T MRI for Detection of Liver Metastases in NET Patients Published in 2023 Listed under Clinical Download [C37] Borbon - Is There a Role for Surgical Resection of Grade 3 Neuroendocrine Neoplasms? Published in 2022 Listed under Clinical Download [C36] Pletcher -vUtility of 68Ga-DOTATATE for Grade 3, Poorly Differentiated Gastroenteropancreatic Neuroendocrine Carcinoma Published in 2023 Listed under Clinical Download [C36] Patel - Safety and Efficacy of Peptide Receptor Radionuclide Therapy in Thymic Neuroendocrine Neoplasms: A Single-Institutional Case Series Published in 2024 Listed under Clinical Download [C35] Wong - Institutional Retrospective Review of Peptide Receptor Radionuclide Therapy Use in Metastatic Paragangliomas and Pheochromocytomas Published in 2023 Listed under Clinical Download [C35] Poster - Jacques - Small bowel obstruction incidence in Lu177 PRRT patients had no impact on overall survival Published in 2024 Listed under Clinical, Poster Download [C35] Limbach - Liver Directed Therapy is Associated with Improved Survival in Metastatic Gastroenteropancreatic Neuroendocrine Neoplasms with Concurrent Bone Metastasis Published in 2022 Listed under Clinical Download [C35] Jacques - Small bowel obstruction incidence in Lu177 PRRT patients had no impact on overall survival Published in 2024 Listed under Clinical Download [C34] Zaidi - Comparative Assessment of 111In-Octreotide Scintigraphy, 68Ga-DOTATOC PET/CT and 18F-FDG PET/ CT in the Staging and Management of Neuroendocrine Tumors (NETs) Published in 2023 Listed under Clinical Download [C34] Tuchayi - Peptide Receptor Radionuclide Therapy with 177 Lu- DOTATATE: A Single Center Experience Published in 2024 Listed under Clinical Download [C34] Poster - Tuchayi - Peptide Receptor Radionuclide Therapy with 177 Lu - DOTATATE: A Single Center Experience Published in 2024 Listed under Clinical, Poster Download [C33] Salem - DOTATATE PET/CT Imaging In Prostate Cancer: Incidental Observations and Potential Future Implications Published in 2023 Listed under Clinical Download [C33] Cass - Corticosteroid prophylaxis did not decrease tumor flare reaction in high-risk neuroendocrine tumors patients treated with 177Lu-DOTATATE Published in 2024 Listed under Clinical Download [C32] Ziogas - Surgical Management of G3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis Published in 2022 Listed under Clinical Download [C32] Trikalinos - Myelodysplasia and leukemia instances after PRRT: Experience from a tertiary institution Published in 2023 Listed under Clinical Download [C32] Bilgin - Outcomes of Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-DOTATATE in Patients with Malignant Pheochromocytoma (PCC) and Paraganglioma (PGL): A Single Institution Retrospective Study Published in 2024 Listed under Clinical Download [C31] Singh - First-Line Efficacy of [177Lu]Lu-DOTA-TATE in Gastroenteropancreatic Neuroendocrine Tumors by Tumor Grade and Primary Origin: Phase 3 NETTER-2 Subgroup Analysis Published in 2024 Listed under Clinical Download [C31] Patel - Goblet Cell Adenocarcinoma (GCA) of the Appendix: Interrogating Proteomics to Identify Potential Actionable Targets Published in 2022 Listed under Clinical Download [C31] Al-Ward - High-Specific-Activity Iodine-131-Meta-Iodo- Benzylguanidine for the Treatment of Advanced Pheochromocytoma and Paraganglioma: A Real-World Study Published in 2023 Listed under Clinical Download [C30] Meloche-Dumas - Liver-Directed Therapy of Neuroendocrine Liver Metastases Published in 2022 Listed under Clinical Download [C30] Maratta - Somatostatin receptor expression of gastroenteropancreatic neuroendocrine tumors: A comprehensive analysis of expression in the era of somatostatin receptor PET imaging Published in 2024 Listed under Clinical Download [C30] Lareef - Novel Alternate (Alt) Response Criteria for early outcome prediction in Pancreatic (P) Neuroendocrine Tumors (NETs): Utilizing banked imaging and radiomics Published in 2023 Listed under Clinical Download [C2] Urrego - Neuroendocrine tumor metastatic to breast: case report and review of the literature Published in 2023 Listed under Clinical Download [C2] Sun - Preliminary clinical activity of surufatinib combined with octreotide LAR in patients with G1/2 gastroenteropancreatic neuroendocrine tumor (GEP-NET) Published in 2024 Listed under Clinical Download [C2] Hunter - Pembrolizumab for the Treatment of Recurrent High Grade Neuroendocrine Neoplasms Published in 2022 Listed under Clinical Download [C29] Poster - D'Souza - Integrating Yttrium - 90 Radioembolization with Capecitabine - Temozolomide for Grade 3 Liver - Dominant Metastatic Neuroendocrine Tumors: Initial Outcomes Published in 2024 Listed under Clinical, Poster Download [C29] Pelle - Small bowel ischemia in patients with midgut neuroendocrine tumors after treatment with 177Lutetium-Dotatate Published in 2023 Listed under Clinical Download [C29] Jha - Diagnostic Performance of PET or PET/CT Utilizing 18F-DOPA, 68Ga-DOTATATE, 18F-FDG, 18F-FDA, and CT and MRI the Detection of VHL-related Pheochromocytoma Published in 2022 Listed under Clinical Download [C29] D'Souza - Initial Outcomes of Integrating Yttrium-90 Radioembolization with Capecitabine-Temozolomide for Grade 3 Liver-Dominant Metastatic Neuroendocrine Tumors Published in 2024 Listed under Clinical Download [C28] Zhou - Liver-directed therapy for metastatic neuroendocrine carcinoma and grade 3 well-differentiated neuroendocrine tumors Published in 2024 Listed under Clinical Download [C28] Poster - Zhou - Liver - directed therapy for metastatic neuroendocrine carcinoma and grade 3 well - differentiated neuroendocrine tumors Published in 2024 Listed under Clinical, Poster Download [C28] Jha - Diagnostic Performance of PET or PET/CT Utilizing 18F-DOPA, 68Ga-DOTATATE, 18F-FDG, 18F-FDA, and CT and MRI in the Detection of MEN2A-relatedpheochromocytoma Published in 2022 Listed under Clinical Download [C28] Chauhan - ETCTN 10450: A phase I trial of peposertib and lutetium 177 DOTATATE in well-differentiated somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Published in 2023 Listed under Clinical Download [C27] Poster - Fidelman - A Pilot Study of Pembrolizumab and Peptide Receptor Radionuclide Therapy for Patients with Metastatic Grade 2/3 Well - Differentiated Neuroendocrine Tumors Published in 2024 Listed under Clinical, Poster Download [C27] Jha - Performance of 68Ga-DOTATATE PET/CT, 18F-FDG PET/CT, CT, and MRI Spine in the Detection of Spinal Bone Metastases in Metastatic Pheochromocytoma/Paraganglioma Published in 2022 Listed under Clinical Download [C27] Fidelman - A Pilot Study of Pembrolizumab and Peptide Receptor Radionuclide Therapy for Patients with Well-Differentiated Neuroendocrine Tumors and Symptomatic and/or Progressive Metastases Published in 2024 Listed under Clinical Download [C27] Chauhan - ETCTN 10388: A first in human Phase I Trial of Triapine and Lutetium Lu 177 DOTATATE in Well-Differentiated Somatostatin Receptor-Positive Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) Published in 2023 Listed under Clinical Download [C26] Meredith - Incidence and Characterization of Carcinoid Crises post Embolization of Neuroendocrine Tumor Liver Metastases Published in 2024 Listed under Clinical Download [C26] Mallak - Pre-therapy Functional Imaging with MIBG and DOTATATE to Guide Radiopharmaceutical Therapy for Pheochromocytoma and Paraganglioma: A Single Institution Experience Published in 2022 Listed under Clinical Download [C26] Fidelman - A Pilot Study of Pembrolizumab and Embolization or 90Y Radioembolization for Patients with Metastatic Well- Differentiated Neuroendocrine Tumors Published in 2023 Listed under Clinical Download [C25] Poster - O'Leary - Associations between patterns of neuroendocrine liver metastatic burden and outcomes after embolization, CapTem and PRRT Published in 2024 Listed under Clinical, Poster Download [C25] O'Leary - Does Liver Tumor Morphology Predict Outcomes after LDT, PRRT or CapTem? Published in 2024 Listed under Clinical Download [C25] Heying - Evaluation of 68Ga-DOTATATE PET After Two Cycles of Peptide Receptor Radionuclide Therapy (PRRT) in Neuroendocrine Tumors (NET) Published in 2022 Listed under Clinical Download [C25] Fidelman - A Pilot Study of Pembrolizumab and Peptide Receptor Radionuclide Therapy for Patients with Metastatic Well- Differentiated Neuroendocrine Tumors Published in 2023 Listed under Clinical Download [C24] Nunez - 68Ga-DOTATATE/18F-FDG dual PET: Utility of the NETPET score in management of G2-3 WD NENs Published in 2023 Listed under Clinical Download [C24] Mittra - MIBG and DOTATATE Therapy for Pheochromocytoma and Paraganglioma: A Single Institution Experience Published in 2022 Listed under Clinical Download [C24] Barnett - Evaluating Time to Treatment Start for Patients Receiving Peptide Receptor Radioligand Therapy Published in 2024 Listed under Clinical Download [C23] Poster - Porfido - Neuroendocrine tumor (NET) progression of disease during or within one year after completion of therapy with 177Lu - DOTATATE Published in 2024 Listed under Clinical, Poster Download [C23] Porfido - Neuroendocrine tumor (NET) progression of disease during or within one year after completion of therapy with 177Lu-DOTATATE Published in 2024 Listed under Clinical Download [C23] Lin - Phase 1/2 study of Lu-177-DOTATATE in combination with olaparib in metastatic or inoperable GI neuroendocrine tumors - first results Published in 2023 Listed under Clinical Download [C23] Al-Toubah - Somatostatin Receptor Expression in Lung Neuroendocrine Tumors: An Analysis of Dotatate PET Scans Published in 2022 Listed under Clinical Download [C22] Prela - The Role of 68Ga-DOTATATE PET/CT in the Management of Gastrointestinal and Pancreatic Neuroendocrine Tumors Published in 2022 Listed under Clinical Download [C22] Poster - Porfido - Multicenter clinical registry of patients with a neuroendocrine tumor (NET) diagnosis receiving 177Lu - DOTATATE Published in 2024 Listed under Clinical, Poster Download [C22] Porfido - Multicenter clinical registry of patients with a neuroendocrine tumor (NET) diagnosis receiving 177Lu-DOTATATE Published in 2024 Listed under Clinical Download [C22] Lin - Phase 2 Trial of Lu-177-DOTATATE in Metastatic or Inoperable Pheochromocytoma/Paraganglioma: Interim Analysis Results Published in 2023 Listed under Clinical Download [C21] Lin - Ratio of total uptake volume on DOTATATE vs FDG PET as a predictive marker of treatment efficacy of Lu-177- DOTATATE in metastatic pheochromocytoma Published in 2023 Listed under Clinical Download [C21] del Rivero - Effect of Absorbed Dose on Toxicity and Tumor Response of Lu-177-DOTATATE With Olaparib in Gastroenteropancreatic Neuroendocrine Patients: Preliminary Results Published in 2024 Listed under Clinical Download [C21] Coston - Characterizing Bone Metastases in Patients with Well-Differentiated Neuroendocrine Neoplasms Utilizing Ga68-DOTATATE PET Published in 2022 Listed under Clinical Download [C20] Yuan - Yttrium 90 transarterial radioembolization of neuroendocrine liver metastasis Published in 2023 Listed under Clinical Download [C20] Sriwastwa - Imaging, Clinical, and Safety Outcomes in Metastatic Neuroendocrine Tumor Patients Treated with Peptide Receptor Radionuclide Therapy in the Midwestern USA Published in 2024 Listed under Clinical Download [C20] Jimenez - Quality of Life Assessments for Advanced Pheochromocytoma and Paraganglioma Patients that Received High-Specific-Activity I-131 MIBG: Results from a Pivotal Phase 2 Clinical Trial Published in 2022 Listed under Clinical Download [C1] Singh - Progression-Free Survival in Patients with Bronchopulmonary Neuroendocrine Tumors Treated with Lanreotide or Placebo: Adjustment for Crossover Effects in Placebo Arm Published in 2022 Listed under Clinical Download [C1] Poster - Mohamed - NP-101 in Combination with Nivolumab and Ipilimumab in Metastatic Extra-pulmonary Neuroendocrine Carcinomas (EP-NECs): A PIlot Study Published in 2024 Listed under Clinical, Poster Download [C1] Mohamed - NP-101 in Combination with Nivolumab and Ipilimumab in Metastatic Extra-pulmonary Neuroendocrine Carcinomas (EP-NECs): A Pilot Study Published in 2024 Listed under Clinical Download [C19] Yadav - The Impact of Post-Treatment Imaging in Peptide Receptor Radionuclide Therapy Published in 2023 Listed under Clinical Download [C19] Poster - Mosalem - Safety of Lutetium-177 DOTATATE Treatment in Patients with Advanced Neuroendocrine Tumors and Extensive/Innumerable Bone Metastases Published in 2024 Listed under Clinical, Poster Download [C19] Moselam - Safety of Lutetium-177 DOTATATE Treatment in Patients with Advanced Neuroendocrine Tumors and Extensive/ Innumerable Bone Metastases Published in 2024 Listed under Clinical Download Select the number of documents per page 5 10 15 20 25 30 50 100 «123…67»
